Bright Minds Biosciences Inc.
DRUG | NASDAQ
$61.14
+$1.68 (+2.83%)
Sep 22, 2026, 1:11 PM ET · Market open
Fiscal Quarter Period Ending | Q3 2026 Jun 29, 2026 | Q2 2026 Mar 30, 2026 | Q1 2026 Dec 30, 2025 | Q4 2025 Sep 29, 2025 | Q3 2025 Jun 29, 2025 | Q2 2025 Mar 30, 2025 | Q1 2025 Dec 30, 2024 | Q4 2024 Sep 29, 2024 | Q3 2024 Jun 29, 2024 | Q2 2024 Mar 30, 2024 | Q1 2024 Dec 30, 2023 | Q4 2023 Sep 29, 2023 | Q3 2023 Jun 29, 2023 | Q2 2023 Mar 30, 2023 | Q1 2023 Dec 30, 2022 | Q4 2022 Sep 29, 2022 | Q3 2022 Jun 29, 2022 | Q2 2022 Mar 30, 2022 | Q1 2022 Dec 30, 2021 | Q4 2021 Sep 29, 2021 | Q3 2021 Jun 29, 2021 | Q2 2021 Mar 30, 2021 | Q1 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -2.46M | -10.63M | -7.57M | -4.09M | -5.24M | -2.95M | 49.61K | -773.44K | 229.9K | -574.14K | -1.68M | -1.53M | -1.46M | -2.05M | -2.34M | -2.96M | -2.66M | -4.49M | -4.86M | -2.87M | -3.53M | -1.58M | -667.06K |
Depreciation & Amortization | 19.97K | 20.13K | 19.79K | 17.01K | 15.85K | 22.48K | 21.53K | 19.02K | -29.89K | 18.11K | 18.11K | 18.11K | 18.11K | 18.11K | 18.11K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | 1.29M | 1.07M | 1.32M | 615.91K | 176.39K | 210.24K | 183.94K | 226.64K | 218.95K | 400.5K | 237.54K | 29.96K | 484.14K | 29.92K | 293.38K | 290.84K | 260.93K | 376.57K | 260.8K | 125.24K | 118.01K |
Other Working Capital | -1.21M | 2.06M | -965.81K | 1.33M | -340.41K | 27.92K | -101.76K | 126.38K | -689.45K | 28.22K | 587.91K | -322.05K | -251.69K | 453.33K | -940.11K | 935.1K | -613.32K | 570.92K | -122.93K | 285.28K | 47.9K | 98.12K | -15.07K |
Other Non-Cash Items | -4.82M | -267.5K | 1.44M | 539.89K | 781.3K | 25.34K | -1.62M | -12.37K | 9.64K | 4.29K | 45.27K | 167.22K | -125.89K | 10.66K | 13.1K | -41.25K | 4.28K | 6.99K | -191.38K | -152.29K | 293.25K | -11.3K | 15.1K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.16M | 1.39M | -996.37K | 1.19M | -379.48K | -138.63K | -118.56K | 93.39K | -153.43K | -479.99K | 579.85K | -255.36K | -322K | 479.25K | -843.6K | 843.75K | -501.36K | 544.2K | -162.47K | 253.12K | 6.67K | 61.87K | -15.57K |
Operating Cash Flow | -8.42M | -9.5M | -5.82M | -1.27M | -3.5M | -2.43M | -1.49M | -463.17K | 240.16K | -805.09K | -822.09K | -1.2M | -1.65M | -1.51M | -2.66M | -2.13M | -2.86M | -3.65M | -4.95M | -2.39M | -2.97M | -1.41M | -549.52K |
Capital Expenditures | n/a | -4.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.88K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.88K |
Debt Repayment | n/a | n/a | -26.03K | -26.11K | -25.62K | -24.63K | -23.79K | -23.86K | -21.96K | -21.96K | -21.96K | -21.65K | -21.49K | -21.49K | -21.49K | 24.84K | n/a | -32K | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.7K | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -26.57K | -27.14K | -536.12K | -276.42K | n/a | n/a | -83.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.06M | 1M | 12K | 33.68K | 118.25K | n/a | -506.3K | -1.2M | 22.88K |
Financial Cash Flow | -2.21M | 232.5M | 13.39M | 33.32M | -16.87K | 225.38K | 52.04M | -23.56K | -21.96K | -21.96K | 878.04K | -21.65K | -21.49K | -21.49K | 2.25M | 5.06M | 12K | 1.68K | 118.25K | -9.7K | -545.55K | 24.71M | 1.9M |
Net Cash Flow | -7.02M | 218.88M | 6.14M | 31.52M | -4.29M | -2.22M | 52.18M | -470.15K | 257.81K | -829.21K | 13.66K | -1.38M | -1.54M | -1.54M | -416.41K | 2.99M | -2.83M | -3.65M | -4.64M | -2.25M | -3.44M | 23.34M | 1.31M |
Free Cash Flow | -8.42M | -9.5M | -5.82M | -1.27M | -3.5M | -2.43M | -1.49M | -463.17K | 240.16K | -805.09K | -822.09K | -1.2M | -1.65M | -1.51M | -2.66M | -2.13M | -2.86M | -3.65M | -4.95M | -2.39M | -2.97M | -1.41M | -549.52K |
Adj. Free Cash Flow | -8.42M | -9.5M | -7.1M | -2.34M | -4.83M | -3.04M | -1.67M | -673.41K | 56.22K | -1.03M | -1.04M | -1.6M | -1.89M | -1.54M | -3.15M | -2.16M | -3.16M | -3.94M | -5.21M | -2.77M | -3.23M | -1.53M | -667.53K |
Maintenance CapEx | n/a | -4.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -8.42M | -9.5M | -5.82M | -1.27M | -3.5M | -2.43M | -1.49M | -463.17K | 240.16K | -805.09K | -822.09K | -1.2M | -1.65M | -1.51M | -2.66M | -2.13M | -2.86M | -3.65M | -4.95M | -2.39M | -2.97M | -1.41M | -549.52K |
Add to Watchlist
Select watchlists to add or remove DRUG